• Exchange: OTC US
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharmaceuticals

Generex Biotechnology Corp

+ Add to Watchlist

GNBT:US

0.0340 USD 0.0023 6.34%

As of 17:20:00 ET on 04/24/2014.

Company Profile for Generex Biotechnology Corp (GNBT)

Generex Biotechnology Corporation researches and develops drug delivery systems and technology. The Company's initial product is an insulin formulation that is administered as a fine spray into the oral cavity using a hand held aerosol applicator. Generex is conducting clinical trials of its product in the United States, Canada, England, and Italy.

Contact Information

Generex Biotechnology Corp

33 Harbour Square
Suite 202
Toronto, ON M5J 2G2
Canada
Phone: 1-416-364-2551
Fax: 1-416-364-9363

Key Executives for Generex Biotechnology Corp (GNBT)

Mark A FletcherPresident/CEO/Gen CnslStephen FellowsActing CFO
David BrusegardCOO/SecretaryEric Von HofeVice President
Todd FallsInvestor Relations

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Advertisements
Advertisement
sec ||= nil